Cerus CORP Form 4 insider transactions

Richard J. Benjamin, Chief Medical Officer of Cerus Corp, sold 21,605 shares of common stock at $2.5 per share on August 2, 2024, according to a Form 4 filing.

Director Dean A. Gregory acquired 60,000 shares of Cerus Corp common stock on July 1, 2024, through the vesting of restricted stock units (RSUs).

Frank Witney, a director of Cerus Corporation, acquired 40,000 shares of common stock at $5 per share on June 5, 2024, increasing his total holdings to 220,059 shares.

Director Daniel N Swisher JR of Cerus Corp acquired 40,000 shares of common stock at $5 per share on June 5, 2024.

Director Hua Shan reports acquiring 40,000 shares of Cerus Corp common stock and disposing of an unspecified amount, according to a Form 4 filing.

Director Gail Schulze acquired 40,000 shares of Cerus Corp common stock on June 5, 2024, increasing their total holdings to 163,420 shares.

Director Jami K Nachtsheim acquired 40,000 shares of Cerus Corp common stock at $5 per share on June 5, 2024, increasing their total holdings to 148,362 shares.

Director Timothy L. Moore of Cerus Corporation reports the acquisition of 40,000 shares of common stock at $5 per share on June 5, 2024.

Director Ann Lucena acquired 40,000 shares of Cerus Corp common stock at $5 per share on June 5, 2024.

Director Eric Bjerkholt acquired 40,000 shares of Cerus Corp common stock on June 5, 2024, at a price of $5 per share.

Director Hua Shan of Cerus Corp (CERS) recently acquired 2,500 shares of common stock at a price of $1.9899 per share.

Director Jami Nachtsheim of Cerus Corp (CERS) recently acquired 2,000 shares of common stock, increasing their total holdings to 108,362 shares.

Director Witney Frank of Cerus Corp (CERS) recently acquired 20,000 shares of common stock at $1.89 per share, increasing their total holdings to 180,059 shares.

Director Daniel N Swisher Jr. of Cerus Corporation (CERS) recently purchased 2,500 shares of common stock at an average price of $1.8755.

Kevin Green, CFO of Cerus Corporation, reported the sale of common stock to cover tax obligations related to vesting restricted stock units.

Carol Moore, SVP of Regulatory & Quality at Cerus Corp, reported the sale of common stock to cover tax obligations related to vesting restricted stock units.

Cerus Corporation's Chief Legal Officer, Chrystal Jensen, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Cerus Corporation's Chief Operating Officer, Vivek K. Jayaraman, reported the sale of company stock to cover tax obligations related to vesting restricted stock units.

Cerus Corporation's CEO, William Greenman, sold shares of common stock to cover statutory tax withholding obligations related to the vesting of restricted stock units.

Laurence M. Corash, Chief Scientific Officer of Cerus Corporation, reported the sale of common stock to cover tax obligations related to vesting restricted stock units.

Cerus Corporation's Chief Medical Officer, Richard J. Benjamin, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Richard J. Benjamin, Chief Medical Officer of Cerus Corporation, sold 29,378 shares of common stock at an average price of $2.3983 on March 8, 2024, under a pre-arranged 10b5-1 trading plan.

Carol Moore, SVP of Regulatory & Quality at Cerus Corporation, reported the acquisition of 75,000 Restricted Stock Units (RSUs) on March 1, 2024.

Chrystal Menard, Chief Legal Officer of Cerus Corporation, acquired 160,000 restricted stock units (RSUs) on March 1, 2024.

Cerus Corporation's Chief Operating Officer, Vivek K. Jayaraman, reports the acquisition of 240,000 restricted stock units (RSUs) in a recent SEC filing.

William Greenman, President and CEO of Cerus Corporation, acquired 575,000 restricted stock units (RSUs) on March 1, 2024.

Kevin Dennis Green, CFO of Cerus Corporation, reports the acquisition of 200,000 restricted stock units (RSUs) and shares purchased under the Employee Stock Purchase Plan.

Chief Scientific Officer Laurence M. Corash acquired 90,000 Restricted Stock Units (RSUs) in Cerus Corporation on March 1, 2024, according to a Form 4 filing.

Cerus Corporation's Chief Medical Officer, Richard J. Benjamin, acquired 160,000 Restricted Stock Units (RSUs) on March 1, 2024, according to a recent SEC filing.